Advertisement

Arcadia Biosciences, Inc. RKDA

Set alert

Price alert · RKDA

All alert types
0.16 USD -0.01 -7.39%

At close · Oct 30

0.15 -0.01 -5.64%

After hours · Oct 30, 6:01 PM ET

Bid
0.14 × 1
Ask
0.16 × 2
0.1368 Day range 0.166
0.145 52-week range 3.90
YTD
-92.03%
1 year
-95.74%
Open
0.152
Prev close
0.1705
Mkt cap
380.41K
Vol
847.42K
Avg vol
1.91M
EPS
-4.55
P/E
0.00
Div yield
0.00%
More statistics
Low
0.1368
High
0.166
Forward P/E
-4.76
Beta
0.00
Short ratio
0.73
Inst. own
4.70%
Dividend
0.00
Ex-div date
50-d avg
4.09
200-d avg
3.03
1y target
9.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 12, 2024Earnings: -0.87; estimate -0.77; surprise -12.99%
Signals (88)
NameDateAgo
MACD: Buy SignalOct 23, 20261 week ago
MACD: Sell SignalSep 24, 20261 month ago
RSI: OversoldSep 24, 20261 month ago
MACD: Buy SignalAug 28, 20262 months ago
MACD: Sell SignalAug 17, 20262 months ago
MACD: Buy SignalJul 6, 20263 months ago
RSI: OversoldJun 24, 20264 months ago
MACD: Sell SignalJun 17, 20264 months ago
MACD: Buy SignalMay 26, 20265 months ago
MACD: Sell SignalMay 21, 20265 months ago
RSI: OversoldMay 21, 20265 months ago
MACD: Buy SignalMay 20, 20265 months ago
MACD: Sell SignalMay 19, 20265 months ago
RSI: OversoldMay 15, 20265 months ago
MACD: Buy SignalApr 29, 20266 months ago
MACD: Sell SignalApr 20, 20266 months ago
RSI: OversoldApr 20, 20266 months ago
MACD: Buy SignalApr 14, 20266 months ago
RSI: OversoldMar 30, 20267 months ago
MACD: Sell SignalMar 17, 20267 months ago
SMA: BearishMar 10, 20267 months ago
SMA: BullishMar 9, 20267 months ago
MACD: Buy SignalFeb 18, 20268 months ago
MACD: Sell SignalFeb 17, 20268 months ago
MACD: Buy SignalFeb 12, 20268 months ago
MACD: Sell SignalFeb 5, 20268 months ago
RSI: OversoldFeb 4, 20269 months ago
MACD: Buy SignalJan 9, 20269 months ago
RSI: OversoldDec 24, 202510 months ago
MACD: Sell SignalDec 23, 202510 months ago
SMA: BearishDec 9, 202510 months ago
SMA: BullishDec 8, 202510 months ago
MACD: Buy SignalDec 1, 202511 months ago
SMA: BullishNov 13, 202511 months ago
SMA: BearishNov 7, 202511 months ago
SMA: BullishNov 6, 202512 months ago
SMA: BearishOct 28, 20251 year ago
SMA: BearishOct 27, 20251 year ago
SMA: BullishOct 24, 20251 year ago
MACD: Sell SignalOct 23, 20251 year ago
SMA: BearishOct 21, 20251 year ago
SMA: BullishOct 15, 20251 year ago
SMA: BullishOct 15, 20251 year ago
RSI: OverboughtOct 15, 20251 year ago
SMA: BearishOct 10, 20251 year ago
SMA: BearishOct 9, 20251 year ago
SMA: BullishOct 8, 20251 year ago
SMA: BullishOct 8, 20251 year ago
RSI: OverboughtOct 8, 20251 year ago
MACD: Buy SignalSep 15, 20251 year ago
RSI: OversoldSep 2, 20251 year ago
SMA: BearishAug 22, 20251 year ago
MACD: Sell SignalAug 21, 20251 year ago
SMA: BearishAug 18, 20251 year ago
SMA: BullishAug 15, 20251 year ago
SMA: BearishAug 14, 20251 year ago
SMA: BullishAug 13, 20251 year ago
SMA: BearishAug 11, 20251 year ago
SMA: BullishAug 8, 20251 year ago
SMA: BearishAug 7, 20251 year ago
SMA: BullishAug 6, 20251 year ago
MACD: Buy SignalAug 6, 20251 year ago
SMA: BearishJul 22, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BearishJul 18, 20251 year ago
MACD: Sell SignalJul 17, 20251 year ago
MACD: Buy SignalJul 10, 20251 year ago
MACD: Sell SignalJun 13, 20251 year ago
RSI: OverboughtJun 6, 20251 year ago
RSI: OverboughtMay 6, 20251 year ago
SMA: BullishApr 30, 20251 year ago
SMA: BearishApr 29, 20251 year ago
SMA: BullishApr 25, 20251 year ago
MACD: Buy SignalApr 9, 20251 year ago
MACD: Sell SignalApr 2, 20251 year ago
RSI: OversoldApr 2, 20251 year ago
RSI: OversoldMar 21, 20251 year ago
MACD: Buy SignalMar 19, 20251 year ago
RSI: OversoldMar 6, 20251 year ago
RSI: OversoldMar 3, 20251 year ago
RSI: OversoldFeb 21, 20251 year ago
SMA: BearishFeb 4, 20251 year ago
SMA: BullishFeb 3, 20251 year ago
SMA: BearishJan 31, 20251 year ago
MACD: Sell SignalDec 31, 20241 year ago
RSI: OverboughtDec 19, 20241 year ago
RSI: OverboughtDec 5, 20241 year ago
RSI: OversoldDec 3, 20241 year ago

Key statistics

Market cap
8.31M
Enterprise value
2.30M
Trailing P/E
0.00
Forward P/E
-4.76
PEG ratio
0.00
Price / sales
1.60
Price / book
0.81
EPS (TTM)
-6.77
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-112.42%
Revenue (TTM)
5.18M
Revenue growth
-3.80%
Free cash flow
-7.37M
Total cash
6.58M
Total debt
346.00K
Return on equity
-52.65%
Shares outstanding
1.36M
Short % of float
0.67%
50-day average
4.09
200-day average
3.03

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 9.00 +5599.8% upside
Target (low)
6.00
Target (mean)
9.00
Target (high)
12.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.50.

Earnings history

Financials — quick view

All financials
RKDA Revenue — quarterly 1.44M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
RKDA Net income — quarterly -6.27M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
RKDA EPS — quarterly -2.09
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

RKDA recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 12, 2024Sep 1, 2024-0.77-0.87-0.10-12.99%
Aug 13, 2024Jun 1, 20241.270.78-0.49-38.58%
May 9, 2024Mar 1, 2024-2.52-1.78+0.74+29.37%
Mar 28, 2024Dec 1, 2023-2.68-2.48+0.20+7.46%
Nov 9, 2023Sep 1, 2023-2.67-1.83+0.84+31.46%
Aug 10, 2023Jun 1, 2023-4.92-2.64+2.28+46.34%

Upgrades / downgrades

RKDA analyst upgrades and downgrades
DateFirmActionFromTo
Aug 21, 2024HC Wainwright & Co.reitBuyBuy
May 23, 2024HC Wainwright & Co.mainBuyBuy
Apr 5, 2024HC Wainwright & Co.reitBuyBuy
Aug 28, 2023HC Wainwright & Co.mainBuyBuy
Jul 24, 2023HC Wainwright & Co.reitBuyBuy
Jun 5, 2023HC Wainwright & Co.mainBuyBuy

About Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Sector
Consumer Defensive
Industry
Packaged Foods
Country
United States

News

Your note

Sign in to keep a note on RKDA — it syncs with the Stock Master app.

Insider holders

RKDA insider holders
InsiderRelationLatest transactionDateShares held
JACOT STANLEY JRChief Executive OfficerPurchaseMay 29, 20235,000
KAWAKAMI MARKChief Financial OfficerPurchaseJul 31, 20241,981
SCHAEFER THOMAS J.Chief Financial OfficerPurchaseAug 3, 2023719

Institution ownership

RKDA institution ownership
Holder% heldSharesValueReported
Mariner, LLC1.83%25,000152.25KSep 29, 2024
Vanguard Group Inc1.03%14,03885.49KSep 29, 2024
State Street Corporation0.89%12,14673.97KSep 29, 2024
Tower Research Capital LLC (TRC)0.13%1,76410.74KSep 29, 2024
Morgan Stanley0.04%6073.70KSep 29, 2024
UBS Group AG0.02%2391.46KSep 29, 2024

Fund ownership

RKDA fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund1.03%14,03885.49KSep 29, 2024
Fidelity Extended Market Index Fund0.56%7,57746.14KOct 30, 2024
Fidelity Total Market Index Fund0.12%1,6269.90KOct 30, 2024
Fidelity Series Total Market Index Fund0.07%1,0066.13KOct 30, 2024
Advertisement